Indeed, in agreement with our observations, postmortem analysis of the frontal cortex from PD patients harboring LRRK2 mutations in the kinase domain (G2019S and I2020T) displayed a marked reduction in CI-M6PR protein expression (Zhao et al., 2018). Here, LRRK2 is linked to Parkinson disease.